NRC · Nasdaq · CIK 0000070487

NRC HEALTH

NRC HEALTH’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 27, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $137.4M and net income of $11.6M, according to its XBRL data on EDGAR. Its EDGAR record lists 13 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$137.4M
Net income, FY2025
$11.6M
Form 4 filings on record, past 12 months
13

Company overview

Legal name (as filed)
NRC HEALTH
Ticker
NRC
SEC Central Index Key (CIK)
0000070487
Business address
LINCOLN, NE
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Accelerated filer
Position in SEC ticker list
#2949 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from NRC HEALTH’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$148.0MFY2021$151.6MFY2022$148.6MFY2023$143.1MFY2024$137.4MFY2025
Net income
$37.5MFY2021$31.8MFY2022$31.0MFY2023$24.8MFY2024$11.6MFY2025
NRC annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$148.0M$151.6M$148.6M$143.1M$137.4M
Net income$37.5M$31.8M$31.0M$24.8M$11.6M
Diluted EPS$1.46$1.27$1.25$1.04$50.00
Total assets$157.5M$130.5M$122.4M$132.5M$134.9M
Cash and equivalents$54.4M$25.0M$6.7M$4.2M$4.1M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = ProfitLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

NRC latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 5, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 4, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 27, 20268-KResults of operations· period Oct 27, 2026Document · Index
May 8, 2026DEF 14ADefinitive proxy statement· period Jun 23, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about NRC HEALTH, by form type:

4 ×138-K ×1010-Q ×3SCHEDULE 13G/A ×2SCHEDULE 13D/A ×2424B7 ×23 ×1DEFA14A ×1DEF 14A ×1ARS ×1PRE 14A ×110-K/A ×1S-8 ×110-K ×1
NRC recent filings
FiledFormWhat it isOriginal
Oct 27, 20268-KResults of operations· period Oct 27, 2026Document · Index
Oct 19, 20268-KDirector or officer change· period Oct 14, 2026Document · Index
Aug 13, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 11, 20268-KDirector or officer change· period Aug 7, 2026Document · Index
Aug 4, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 28, 20268-KResults of operations· period Jul 28, 2026Document · Index
Jun 29, 20268-KCharter, bylaws or fiscal year change; Shareholder vote results· period Jun 23, 2026Document · Index
Jun 25, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026Document · Index
Jun 25, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026Document · Index
Jun 25, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026Document · Index
Jun 25, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026Document · Index
Jun 25, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026Document · Index
Jun 12, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
May 13, 2026424B7424B7Document · Index
May 8, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
May 8, 2026DEF 14ADefinitive proxy statement· period Jun 23, 2026Document · Index
May 8, 2026ARSARS· period Dec 31, 2025Document · Index
May 6, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Apr 28, 2026PRE 14APRE 14A· period Jun 23, 2026Document · Index
Apr 28, 202610-K/AAmended annual report· period Dec 31, 2025Document · Index
Apr 28, 20268-KDirector or officer change· period Apr 27, 2026Document · Index
Apr 28, 20268-KResults of operations· period Apr 28, 2026Document · Index
Apr 20, 20268-KDirector or officer change; Charter, bylaws or fiscal year change· period Apr 15, 2026Document · Index
Mar 27, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Mar 13, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 12, 2026Document · Index
Mar 5, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Mar 5, 202610-KAnnual report· period Dec 31, 2025Document · Index
Mar 5, 20268-KRegulation FD disclosure· period Mar 4, 2026Document · Index
Feb 19, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 17, 2026Document · Index
Feb 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 22, 2026Document · Index
Feb 17, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 22, 2026Document · Index
Feb 13, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Feb 10, 2026424B7424B7Document · Index
Feb 3, 20268-KResults of operations· period Feb 3, 2026Document · Index
Jan 26, 20264Statement of changes in beneficial ownership (insider trade)· period Dec 29, 2025Document · Index
Jan 16, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 5, 2026Document · Index
Jan 16, 20263Initial statement of beneficial ownership· period Jan 5, 2026Document · Index
Jan 7, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 5, 2026Document · Index
Dec 17, 20254Statement of changes in beneficial ownership (insider trade)· period Dec 15, 2025Document · Index
Nov 7, 202510-QQuarterly report· period Sep 30, 2025Document · Index

Insider filing activity

13 Form 4 filings appear in NRC HEALTH’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Services-Commercial Physical & Biological Research

All 8 companies in Services-Commercial Physical & Biological Research· Companies headquartered in Nebraska

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000070487 and XBRL company facts. NRC HEALTH on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.